SCP & CO Healthcare Acquisition Company does not have significant business. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to identify a prospective target business in the healthcare technology or healthcare-related industries in the United States and other developed countries. SCP & CO Healthcare Acquisition Company was incorporated in 2020 and is based in Tampa, Florida.
IPO Year: 2021
Exchange: NASDAQ
Website: scpandco.com
| Date | Price Target | Rating | Analyst |
|---|
SC 13G/A - SCP & CO Healthcare Acquisition Co (0001820160) (Subject)
SC 13G/A - SCP & CO Healthcare Acquisition Co (0001820160) (Subject)
SC 13G - SCP & CO Healthcare Acquisition Co (0001820160) (Subject)
SC 13G/A - SCP & CO Healthcare Acquisition Co (0001820160) (Subject)
SC 13G - SCP & CO Healthcare Acquisition Co (0001820160) (Subject)
SC 13G - SCP & CO Healthcare Acquisition Co (0001820160) (Subject)
WNS (Holdings) Limited (NYSE:WNS), a leading provider of global Business Process Management (BPM) solutions, today announced the appointment of Timothy L. Main to the company's Board of Directors effective June 1, 2021. Tim has spent his entire career in a B2B services/outsourcing environment, including more than 25 years with Jabil, Inc. (NYSE:JBL), a leading provider of manufacturing services with a global operational footprint. At Jabil, Tim worked his way from a Production Control Manager position to eventually serve as President, Chief Executive Officer, and Chairman of the Board. During his 13-year tenure as Chief Executive Officer of Jabil, he led the company's transformation and gro
3 - SCP & CO Healthcare Acquisition Co (0001820160) (Issuer)
Tampa, FL, Dec. 09, 2022 (GLOBE NEWSWIRE) -- On December 8, 2022, the stockholders of SCP & CO Healthcare Acquisition Company (the "Company") approved an amendment to the Company's amended and restated certificate of incorporation (the "Charter Amendment") to allow the Company to unwind and redeem all of its outstanding public shares prior to December 30, 2022. The Company filed the Charter Amendment with the Secretary of State of the State of Delaware on December 8, 2022. Following the implementation of the Charter Amendment, the Board of Directors of the Company set December 9, 2022 as the amended termination date. The Company has also requested the Nasdaq Stock Market LL
WNS (Holdings) Limited (NYSE:WNS), a leading provider of global Business Process Management (BPM) solutions, today announced the appointment of Timothy L. Main to the company's Board of Directors effective June 1, 2021. Tim has spent his entire career in a B2B services/outsourcing environment, including more than 25 years with Jabil, Inc. (NYSE:JBL), a leading provider of manufacturing services with a global operational footprint. At Jabil, Tim worked his way from a Production Control Manager position to eventually serve as President, Chief Executive Officer, and Chairman of the Board. During his 13-year tenure as Chief Executive Officer of Jabil, he led the company's transformation and gro
15-12G - SCP & CO Healthcare Acquisition Co (0001820160) (Filer)
8-K - SCP & CO Healthcare Acquisition Co (0001820160) (Filer)
25-NSE - SCP & CO Healthcare Acquisition Co (0001820160) (Subject)
DEFR14A - SCP & CO Healthcare Acquisition Co (0001820160) (Filer)
DEFR14A - SCP & CO Healthcare Acquisition Co (0001820160) (Filer)
DEF 14A - SCP & CO Healthcare Acquisition Co (0001820160) (Filer)
10-Q - SCP & CO Healthcare Acquisition Co (0001820160) (Filer)
PRE 14A - SCP & CO Healthcare Acquisition Co (0001820160) (Filer)
8-K - SCP & CO Healthcare Acquisition Co (0001820160) (Filer)
10-K/A - SCP & CO Healthcare Acquisition Co (0001820160) (Filer)